Cargando…
Clinical applications of azithromycin microspheres in respiratory tract infections
Few adequately designed clinical trials have addressed optimal treatment duration in lower respiratory tract infections. Drugs possessing favourable pharmacokinetic and pharmacodynamic profiles may obtain early bacterial eradication allowing shorter treatment duration. This may be associated with a...
Autores principales: | Blasi, Francesco, Aliberti, Stefano, Tarsia, Paolo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676803/ https://www.ncbi.nlm.nih.gov/pubmed/18203423 |
Ejemplares similares
-
Mixed community-acquired lower respiratory tract infections
por: Tarsia, Paolo, et al.
Publicado: (2007) -
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
por: Blasi, Francesco, et al.
Publicado: (2007) -
The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019) -
Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017) -
Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection
por: Cosentini, Roberto, et al.
Publicado: (2008)